Addition of Generic Medication Vouchers to a Pharmacist Academic Detailing Program: Effects on the Generic Dispensing Ratio in a Physician-Hospital Organization

Bhargava, Vinay; Greg, Mark; Shields, Mark

doi:10.18553/jmcp.2010.16.6.384

Cited by 16 publications

(14 citation statements)

References 5 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The organization had witnessed success in the generic medication voucher program, increasing the number of generics and vouchers used within a short time period, and wished to build upon the success of this program. 2 Consequently, a full-time oncology clinical pharmacist position was created to ensure appropriate use of specialty/ oncology medications and to minimize variance in how these therapies were utilized.…”

Section: ■■ Methods the Oncology Clinical Pharmacistmentioning

confidence: 99%

Best Practices in Specialty Pharmacy Management

Patterson¹

2013

JMCP

View full text Add to dashboard Cite

BACKGROUND: Specialty pharmacy is a growing area of research, utilization, and cost. Because of the unique nature of the diseases treated by specialty pharmaceuticals, such as cancer and rheumatoid arthritis, novel management approaches are needed. Advocate Physician Partners (APP) is an entity within the Advocate Health Care Health System in the Chicago and the central Illinois area. It coordinates the care management and managed care contracting between the Advocate Health Care System and more than 4,000 physicians on the medical staffs of Advocate hospitals.APP has experienced a per-member-per-month (PMPM) increase of < 3% in oncology intravenous medications spend in 2012. This spend refers to the intravenous medications covered under the medical benefits for APP's health maintenance organization (HMO) population. The spend has consistently been less than national projections, and we believe this is tied to the adoption of several key best practices. Prior to instituting the best practices, the yearly percentage increases for oncology spending were 5.52%

show abstract

Section: ■■ Methods the Oncology Clinical Pharmacistmentioning

confidence: 99%

Best Practices in Specialty Pharmacy Management

Patterson¹

2013

JMCP

View full text Add to dashboard Cite

show abstract

“…All used secondary data from prescription records and drug sales. A study was conducted in a high-middle-income country 16 and 16 in high-income countries 3,17,25,26,[30][31][32][35][36][37][38][39][40][41][42] . The selected designs were two RCTs, five NRCTs, seven CBAs and three ITS.…”

Section: Evidence Quality Evaluationmentioning

confidence: 99%

“…The selected designs were two RCTs, five NRCTs, seven CBAs and three ITS. The interventions were found to be educational 3,[16][17][18]25,26,[30][31][32]35 , of financial incentive 4,32,36,37 , electronic prescription 38,39 and managerial 40 . The main characteristics of the studies are summarized in Chart 1.…”

Section: Evidence Quality Evaluationmentioning

confidence: 99%

“…Bhargava et al 36 and Scott et al 37 made financial interventions on the prescriber. The study subjects of Bhargava et al 36 were primary care Table 1.…”

Section: Financial Incentive Interventionsmentioning

confidence: 99%

“…The study subjects of Bhargava et al 36 were primary care Table 1. Evaluation of risk of bias of selected studies on interventions that promote the use of generic drugs.…”

Section: Financial Incentive Interventionsmentioning

confidence: 99%

See 2 more Smart Citations

Impacto de intervenções para promoção do uso de medicamentos genéricos: revisão sistemática

Guttier

Silveira²,

Luiza

et al. 2017

Ciênc. saúde coletiva

View full text Add to dashboard Cite

show abstract

Pharmaceutical policies: effects of financial incentives for prescribers

Rashidian

Omidvari

Vali

et al. 2015

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Although financial incentives are considered an important element in strategies to change prescribing patterns, limited evidence of their effects can be found. Effects of policies, including pay for performance policies, in improving quality of care and health outcomes remain uncertain. Because pharmaceutical policies have uncertain effects, and because they might cause harm as well as benefit, proper evaluation of these policies is needed. Future studies should consider the impact of these policies on health outcomes, drug use and overall healthcare expenditures, as well as on drug expenditures.

show abstract

Addition of Generic Medication Vouchers to a Pharmacist Academic Detailing Program: Effects on the Generic Dispensing Ratio in a Physician-Hospital Organization

Cited by 16 publications

References 5 publications

Best Practices in Specialty Pharmacy Management

Best Practices in Specialty Pharmacy Management

Impacto de intervenções para promoção do uso de medicamentos genéricos: revisão sistemática

Pharmaceutical policies: effects of financial incentives for prescribers

Contact Info

Product

Resources

About